Top

BMC Endocrine Disorders

Published in:

Open Access 01-12-2014 | Research article

Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials

Authors: Sunya-Lee Antoine, Dawid Pieper, Tim Mathes, Michaela Eikermann

Published in: BMC Endocrine Disorders | Issue 1/2014

Abstract

Background

Oral medication for patients with type 2 diabetes mellitus plays an important role in diabetes care and is associated with a high level self-care behavior and self-management. However, poor adherence to diabetes treatment is common which causes severe health complications and increased mortality. Barriers to adherence may consist of complex treatment regimens often along with long-term multi-therapies, side effects due to the medication as well as insufficient, incomprehensible or confusing information or instructions provided by the health care provider. Multidisciplinary approaches can support adherence success and can enable a more effective management of diabetes care. One approach in diabetes care can be the involvement of a pharmacist. The aim was to analyze the effectiveness of adherence-enhancing pharmacist interventions for oral medication in type 2 diabetes mellitus.

Methods

A systematic review of randomized controlled trials. The study quality was assessed with the Cochrane risk of bias tool.

Results

Of 491 hits, six publications were included. Two studies mainly examining educational interventions showed a significant improvement in adherence. Moreover, the quality of the included studies was deficient.

Conclusion

Although pharmacist interventions might potentially improve adherence to type 2 diabetes mellitus medication, high-quality studies are needed to assess effectiveness.

Available only for authorised users

World Health Organisation (WHO): Adherence to Long-Term Therapies-Evidence for action. 2003

Cramer JA, Okikawa J, Bellaire S, Clauson P: Compliance with inhaled insulin treatment using the AERx(registered trademark) iDMS insulin diabetes management system. Diab Technol Ther. 2004, 6 (6): 800-807.CrossRef

Vermeire EIJJ, Wens J, Van Royen P, Biot Y, Hearnshaw H, Lindenmeyer A: Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005, CD003638-2

Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ: Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006, 166 (17): 1836-1841. PubMed PMID: 17000939. Epub 2006/09/27. engCrossRefPubMed

Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, Burton CM, Evans M: The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care. 2012, 35 (6): 1279-1284. PubMed PMID: 22511257. Pubmed Central PMCID: 3357221. Epub 2012/04/19. engCrossRefPubMedPubMedCentral

World Health Organisation (WHO): Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. 1999

Nam S, Chesla C, Stotts NA, Kroon L, Janson SL: Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract. 2011, 93 (1): 1-9. PubMed PMID: 21382643. Epub 2011/03/09. engCrossRefPubMed

Odegard PS, Gray SL: Barriers to medication adherence in poorly controlled diabetes mellitus. Diab Educ. 2008, 34 (4): 692-697.CrossRef

Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, Giri M: Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial. J Clin Pharm Ther. 2011, 36 (5): 602-613.CrossRefPubMed

10.

Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y: Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Ther. 2006, 31 (5): 409-419. PubMed PMID: 16958818. Epub 2006/09/09. engCrossRefPubMed

11.

Spinewine A, Fialova D, Byrne S: The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012, 29 (6): 495-510. PubMed PMID: 22642783. Epub 2012/05/31. engCrossRefPubMed

12.

Hume AL, Kirwin J, Bieber HL, Couchenour RL, Hall DL, Kennedy AK, LaPointe NM, Burkhardt CD, Schilli K, Seaton T, Trujillo J, Wiggins B: Improving care transitions: current practice and future opportunities for pharmacists. Pharmacotherapy. 2012, 32 (11): e326-e337. PubMed PMID: 23108810. Epub 2012/10/31. engCrossRefPubMed

13.

World Health Organisation (WHO): The Role of the Pharmacist in the Health Care System. 1993

14.

Omran D, Guirguis LM, Simpson SH: Systematic review of pharmacist interventions to improve adherence to oral antidiabetic medications in people with type 2 diabetes. Can J Diab. 2012, 36 (5): 292-299.CrossRef

15.

Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK: Medication compliance and persistence: terminology and definitions. Value Health. 2008, 11 (1): 44-47.CrossRefPubMed

16.

Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group, Cochrane Statistical Methods Group: The cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011, 343: d5928-PubMed PMID: 22008217. Pubmed Central PMCID: 3196245CrossRefPubMedPubMedCentral

17.

Hartling L, Hamm MP, Milne A, Vandermeer B, Santaguida PL, Ansari M, Tsertsvadze A, Hempel S, Shekelle P, Dryden DM: Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs. J Clin Epidemiol. 2013, 66 (9): 973-981. PubMed PMID: 22981249. Epub 2012/09/18. engCrossRefPubMed

18.

Hartling L, Ospina M, Liang Y, Dryden DM, Hooton N, Seida JK, Klassen TP: Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ. 2009, 37 (09): 339-2009-10-19 11

19.

Adepu R, Ari SM: Influence of structured patient education on therapeutic outcomes in diabetes and hypertensive patients. Asian J Pharm Clin Res. 2010, 3 (3): 174-178.

20.

Grant RW, Devita NG, Singer DE, Meigs JB: Improving adherence and reducing medication discrepancies in patients with diabetes. Ann Pharmacother. 2003, 37 (7–8): 962-969.CrossRefPubMed

21.

Obreli-Neto PR, Guidoni CM, De Oliveira BA, Pilger D, Cruciol-Souza JM, Gaeti-Franco WP, Cuman RKN: Effect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patients. Int J Clin Pharm. 2011, 33 (4): 642-649.CrossRefPubMed

22.

Odegard PS, Goo A, Hummel J, Williams KL, Gray SL: Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005, 39 (3): 433-440.CrossRefPubMed

23.

Phumipamorn S, Pongwecharak J, Soorapan S, Pattharachayakul S: Effects of the pharmacist's input on glycaemic control and cardiovascular risks in Muslim diabetes. Prim Care Diab. 2008, 2 (1): 31-37.CrossRef

24.

Heisler M, Hofer TP, Schmittdiel JA, Selby JV, Klamerus ML, Bosworth HB, Bermann M, Kerr EA: Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. Circulation. 2012, 125 (23): 2863-2872. PubMed PMID: 22570370. Epub 2012/05/10. engCrossRefPubMedPubMedCentral

25.

Bogner HR, Morales KH, de Vries HF, Cappola AR: Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial. Ann Fam Med. 2012, 10 (1): 15-22. PubMed PMID: 22230826. Pubmed Central PMCID: 3262455CrossRefPubMedPubMedCentral

26.

Chan CW, Siu SC, Wong CK, Lee VW: A pharmacist care program: positive impact on cardiac risk in patients with type 2 diabetes. J Cardiovasc Pharmacol Ther. 2012, 17 (1): 57-64. PubMed PMID: 21335480CrossRefPubMed

27.

Cohen LB, Taveira TH, Khatana SA, Dooley AG, Pirraglia PA, Wu WC: Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diab Educ. 2011, 37 (6): 801-812. PubMed PMID: 22021025. Epub 2011/10/25. engCrossRef

28.

Farmer A, Hardeman W, Hughes D, Prevost A, Kim Y, Craven A, Oke J, Boase S, Selwood M, Kellar I, Graffy J, Griffin S, Sutton S, Kinmonth AL: An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes. BMC Fam Pract. 2012, 13 (1): 1-9. EnglishCrossRef

29.

Iram M, Pais N, Rani S: Impact Of Patient Counseling And Education Of Diabetic Patients In Improving Their Quality Of Life 2010. 2010, 18-22.

30.

Jacobs M, Sherry PS, Taylor LM, Amato M, Tataronis GR, Cushing G: Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (PAMPERED) study. J Am Pharm Assoc. 2012, 52 (5): 613-621. PubMed PMID: 23023841. Epub 2012/10/02. engCrossRef

31.

Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T: Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in jordan. J Manag Care Pharm. 2012, 18 (7): 516-526.PubMed

32.

Planas LG, Crosby KM, Mitchell KD, Farmer KC: Evaluation of a hypertension medication therapy management program in patients with diabetes. JAPhA. 2009, 49 (2): 164-170.PubMed

33.

Ramanath KVYLS: Impact of clinical pharmacist provided patient education on QOL outcome in type II diabetes mellitus in rural population. Asian J Pharma Clin Res. 2011, 4 (4): 15-20.

34.

Al Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC: Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol. 2009, 67 (5): 547-557.CrossRefPubMedPubMedCentral

35.

Clifford RM, Batty KT, Davis TME, Davis W, Stein G, Stewart G, Plumridge RJ: A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic. Int J Pharm Pract. 2002, 10 (2): 85-89.CrossRef

36.

Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M: Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci. 2011, 16 (1): 43-49.PubMedPubMedCentral

37.

Kirwin JL, Cunningham RJ, Sequist TD: Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial. J Manag Care Pharm. 2010, 16 (2): 104-113.PubMed

38.

Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J, Lau P, Peterson G, Stewart K, Taylor S, Wilkinson J: The pharmacy diabetes care program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med. 2007, 24 (6): 677-683.CrossRefPubMed

39.

Skaer TL, Sclar DA, Markowski DJ, Won JKH: Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures - a study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther. 1993, 18 (4): 295-299.CrossRefPubMed

40.

Suppapitiporn S, Chindavijak B, Onsanit S: Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial. J Med Assoc Thai. 2005, 88 (Suppl 4): S134-S141.PubMed

41.

Jerant A, DiMatteo R, Arnsten J, Moore-Hill M, Franks P: Self-report adherence measures in chronic illness: retest reliability and predictive validity. Med Care. 2008, 46 (11): 1134-1139. PubMed PMID: 18953223. Epub 2008/10/28. engCrossRefPubMed

42.

Gonzalez JS, Schneider HE, Wexler DJ, Psaros C, Delahanty LM, Cagliero E, Safren SA: Validity of medication adherence self-reports in adults with type 2 diabetes. Diabetes Care. 2013, 36 (4): 831-837.CrossRefPubMedPubMedCentral

43.

Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC: Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2012, 5: CD008165-PubMed PMID: 22592727. Epub 2012/05/18. engPubMed

44.

Ahmad A, Hugtenburg J, Welschen LM, Dekker JM, Nijpels G: Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial. BMC Public Health. 2010, 10: 133-CrossRefPubMedPubMedCentral

45.

Tonna APSD, McCaig D: An international overview of some pharmacist prescribing models. J Malta Coll Pharm Pract. 2008, 20-26. Issue 14

46.

Anderson S: The state of the world's pharmacy: a portrait of the pharmacy profession. J Interprof Care. 2002, 16 (4): 391-404. PubMed PMID: 12487847. Epub 2002/12/19. engCrossRefPubMed

47.

Lutz EMRJ, Mattingly J, Reed BN: Pharmacy practice around the world. J Am Pharm Assoc. 2009, 49 (1): 4-10.CrossRef

48.

Schnipper JL, Kirwin JL, Cotugno MC, Wahlstrom SA, Brown BA, Tarvin E, Kachalia A, Horng M, Roy CL, McKean SC, Bates DW: Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006, 166 (5): 565-571.CrossRefPubMed

49.

Melchiors A, Correr C, Venson R, Pontarolo R: An analysis of quality of systematic reviews on pharmacist health interventions. Int J Clin Pharm. 2012, 34 (1): 32-42. EnglishCrossRefPubMed

50.

Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh A: Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care. 2006, 15 (1): 23-31. PubMed PMID: 16456206. Pubmed Central PMCID: 2563996. Epub 2006/02/04. engCrossRefPubMedPubMedCentral

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6823/14/53/prepub

Title: Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials
Authors: Sunya-Lee Antoine
Dawid Pieper
Tim Mathes
Michaela Eikermann
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: BMC Endocrine Disorders / Issue 1/2014
Electronic ISSN: 1472-6823
DOI: https://doi.org/10.1186/1472-6823-14-53

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials

Abstract

Background

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2014

Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial

Emotionally induced galactorrhoea in a non-lactating female –“Pseudo- Lactation”?

Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up

Health-related quality of life 5 years after carpal tunnel release among patients with diabetes: a prospective study with matched controls

Metabolic syndrome among a middle-aged population in the Red River Delta region of Vietnam

Association between metabolic syndrome and bone fractures: a meta-analysis of observational studies

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page